| Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer | prostate, |
| Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. | skin, |
| The transcription factor MITF is an amplified oncogene in melanoma that is critical for anchoring lineage dependence and malignant character. | skin, |
| Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. | skin, |
| A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF. | skin, |
| MITF has an important oncogenic function in tumorigenesis of multiple tissues/melanocytes and kidney cells (Review) | kidney, |
| Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation. | skin, |
| MITF protein is a key regulator of melanocyte development and a lineage-specific oncogene is melanoma development. | skin, |
| Data show that poly(ADP-ribose) polymerase 1 (PARP1)-mediated senescence rescue was accompanied by transcriptional activation of the melanocyte-lineage survival oncogene MITF, indicating a role for PARP1 in melanomagenesis. | skin, |
| MITF represents a distinct class of _lineage survival_ or _lineage addiction_ oncogenes required for both tissue-specific cancer development and tumour progression | None |
| From integrated genomics to tumor lineage dependency. | None |